Skip to search formSkip to main contentSkip to account menu

rhAPC

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
RESULTS. Three hundred and thirty patients were enrolled in this analysis: severe sepsis (29.4%) or septic shock (70.6%) admitted… 
2008
2008
t Background d Recombinantt human activated protein C (rhAPC) is the first drug for which a reduction of mortalityy in severe… 
2008
2008
Die Sterblichkeit von Patienten mit sep­ tischem Schock ist weiterhin inakzeptabel hoch [1]. Die Letalitätsrate ist zwar in den… 
2006
2006
Objectiveive To study cloning of rhAPC gene, constructing expression vector and expression of rhAPC in mammalian cells. Methods… 
2005
2005
We found that under both high and low coagulant challenge clotting time was dosedependently prolonged, thrombin potential and… 
2004
2004
Dear Sir, táíÜ ÖêÉ~í áåíÉêÉëí ïÉ Ü~îÉ êÉ~Ç íÜÉ êÉÅÉåí ã~åìëÅêáéí ENF ~Äçìí íÜÉ ÉÑÑÉÅíë çÑ ~Åíáî~íÉÇ êÉÅçãÄáå~åí Üìã~å mêçíÉáå ` E… 
2003
2003
560 The study entitled “Drotrecogin Alfa (activated) (recombinant human protein C, rhAPC) reduces host coagulopathy response in… 
2002
2002
Klinische Manifestation eines schweren Protein-C-Mangels ist die Purpura fulminans. Bei angeborenem Protein-C-Mangel tritt diese…